BB Biotech AG (BION) — Cash Flow Reinvestment Rate
Latest as of March 2025:
0.00x
BB Biotech AG (BION) has a Cash Flow Reinvestment Rate of 0.00x as of March 2025, reinvesting CHF0.00 (capex CHF0.00 ) from operating cash flow of CHF289.15 Million. See BION net asset quality index to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
CHF0.00
Capex + Investments
Operating Cash Flow
CHF289.15 Million
CHF
Capital Expenditures
CHF0.00
CHF
BB Biotech AG Cash Flow Reinvestment Rate (2004–2025)
Historical reinvestment intensity for BB Biotech AG across 15 annual periods. Also explore BB Biotech AG balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for BB Biotech AG (2004–2025)
Year-by-year capital reinvestment analysis for BB Biotech AG. For live market cap and broader valuation context, see BION market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | CHF0.00 | CHF309.14 Million | CHF0.00 | — |
| 2024 | 0.00x | CHF0.00 | CHF304.56 Million | CHF0.00 | — |
| 2023 | 0.00x | CHF0.00 | CHF218.28 Million | CHF0.00 | — |
| 2020 | 0.00x | CHF0.00 | CHF262.45 Million | CHF0.00 | — |
| 2019 | 0.00x | CHF0.00 | CHF215.02 Million | CHF0.00 | — |
| 2017 | 0.00x | CHF0.00 | CHF687.50 Million | CHF0.00 | — |
| 2015 | 0.00x | CHF0.00 | CHF652.82 Million | CHF0.00 | — |
| 2014 | 0.00x | CHF0.00 | CHF1.47 Billion | CHF0.00 | — |
| 2013 | 0.00x | CHF0.00 | CHF931.83 Million | CHF0.00 | — |
| 2012 | 0.00x | CHF0.00 | CHF367.83 Million | CHF0.00 | — |
| 2011 | 0.00x | CHF0.00 | CHF169.52 Million | CHF0.00 | — |
| 2009 | 0.00x | CHF0.00 | CHF167.84 Million | CHF0.00 | — |
| 2008 | 0.00x | CHF0.00 | CHF509.39 Million | CHF0.00 | — |
| 2007 | 0.00x | CHF0.00 | CHF201.02 Million | CHF0.00 | — |
| 2004 | 0.00x | CHF0.00 | CHF107.32 Million | CHF0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow